Interstitial lung disease associated with antiandrogen agents: a pharmacovigilance study based on FDA adverse event reporting system

International Urology and Nephrology 2026

View at publisher
Authors: Guangrun Li, Xi Zhang, Zhuo Ma, Congrong Ma, Zhuoling An
DOI: 10.1007/s11255-026-05205-1
Cited by: 1
References: 32

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pharmacovigilance and Adverse Drug Reactions Lung Cancer Treatments and Mutations

Publication details

Journal / source
International Urology and Nephrology
Publisher
Springer Science and Business Media LLC
Publication date
19 May 2026
Language
EN